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Membranes
Jared Lee Johnson, Jon W. Erickson, Richard A. Cerione.
Cornell University, Ithaca, NY, USA.
The Rho Family GTPases are a tightly regulated class of signaling proteins
that control a number of important cellular processes. Known most promi-
nently for their ability to remodel the actin cytoskeleton in mammalian cells,
this family has been shown to play essential roles in cell migration, epithelial
cell polarization, phagocytosis, secretion, and cell cycle progression. These
outcomes occur in many different subcellular locations and, as such, they re-
quire the GTPase to be able to quickly access them. Rho Guanine nucleotide
Dissociation Inhibitor (Rho-GDI) is a ubiquitously expressed protein that
stimulates the removal of Rho family GTPases from membranes and has
been shown to be important in regulating their localization. This study em-
ploys a novel FRET assay to reconstitute Rho family GTPase interactions
with GDI at the membrane surface. Cdc42 was loaded with fluorescently la-
beled guanine nucleotides (Mant-nucleotides) and inserted into fluorescein la-
beled membranes that can quench Mant fluorescence by FRET. GDI’s re-
moval of Cdc42-bound Mant-nucleotide from the proximity of acceptor
labeled lipids was demonstrated by the complete restoration of Mant fluores-
cence upon GDI addition. This assay is able to provide detailed kinetic infor-
mation and shed light on the molecular basis of the Cdc42’s interaction with
GDI. Additionally, we are able to probe the nature of the interaction between
Cdc42 and the membrane surface, using liposomes of variable lipid composi-
tion. Here, we demonstrate a direct role for PIP2 on Cdc42’s affinity for mem-
branes and we identify the residues of Cdc42 that are receptive to this lipid,
providing a more detailed understanding of Cdc42’s behavior at the mem-
brane surface in living cells.
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The light-activated rhodopsin, metarhodopsin II, forms a complex with the al-
pha subunit of transducin (Ta). The exchange of GDP for GTP leads to a con-
formational change of Ta which is released from its beta-gamma subunits and
rhodopsin. Ta-GTP then activates cGMP phosphodiesterase (PDE) which hy-
drolyzes cGMP and leads to the closure of the cGMP-gated channels and to the
hyperpolarization of the rod photoreceptors. PDE is made of two catalytic (ab)
and two inhibitory (g) subunits (Pabgg). PDE is acylated with a farnesyl and
a geranylgeranyl and is thus membrane bound. PDE was found to be located, at
least in part, to detergent-resistant membrane microdomains. These microdo-
mains, also called rafts, have been shown to contain a large amount of phospho-
lipids with saturated fatty acyl chains as well as cholesterol. However, the pref-
erential binding of PDE to saturated phospholipids has not yet been shown. The
objectives of this research work were thus to characterize the membrane bind-
ing properties of PDE using Langmuir monolayers. The Pabgg was isolated
and purified from bovine rod outer segments (ROS) of retinal photoreceptors.
PDE was injected into the subphase underneath phospholipid monolayers bear-
ing different fatty acyl chains (length and unsaturation) and polar headgroups
such as those present in ROS. PDE binding was monitored by surface pressure
measurements. The injection of PDE underneath phospholipid monolayers led
to an increase in surface pressure which indicates its membrane binding. The
surface pressure data demonstrated that the adsorption kinetics of PDE is de-
pendent on the type of phospholipid fatty acyl chain (length and unsaturation)
and headgroup. For example, on the basis of its maximum insertion pressure,
PDE shows a preferential binding onto saturated phospholipid monolayers.
This data is consistent with the possible localization of PDE to lipid rafts of
ROS membrane.
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a2-Adrenergic receptors belong to a large family of membrane proteins,
known as G-protein coupled receptors (GPCRs), involved in signallingacross biological membranes. The association of GPCRs to the plasma mem-
brane makes them susceptible to their lipid environment and in turn, these
proteins are also capable of modulating the lipid structure and properties
of the membranes with which they interact. To study peptide-lipid interac-
tions, model peptides consisting of a simple repeating motif designed to
form stable a-helices have been the most common approach used [1]. Our
experimental design followed a novel strategy using peptides with identical
sequences to the putative transmembrane segments (TM), H4, H6 and H7
helix, of the human a2-adrenergic receptor subtype C10 (P08913). P6 pep-
tide contains the hydrophobic and the hydrophilic terminal sequence of the
full TMH segment (H6), whereas P4 and P7 peptides only have the hydro-
phobic core of the transmembrane segments (TM) (H4 and H7). Molecular
and structural parameters of peptide-DEPE membranes have been analyzed
by fluorescence, DSC, X-ray diffraction and FTIR techniques. The study
highlights the importance of the conceptual design of the peptide sequences
using naturally derived aminoacid sequences when mimicking TM proteins
as templates.
[1] J. A. Killian, T. K. Nyholm. 2006. Curr Opin Struct Biol. 16:473-479
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The protein kinase AKT1 regulates multiple signaling pathways essential for
cell function. Its N-terminal PH domain (AKT1 PH) binds the rare signaling
phospholipid, phosphatidylinositol-3,4,5-trisphosphate [PI(3,4,5)P3], result-
ing in plasma membrane targeting and phosphoactivation of AKT1 by
a membrane-bound kinase. Recently it was discovered that the Glu17Lys
mutation in the AKT1 PH domain is associated with multiple human can-
cers. This mutation constitutively targets AKT1 PH domain to plasma mem-
brane by an unknown mechanism, thereby promoting PI(3,4,5)P3-indepen-
dent activation of AKT1 and oncogenesis. To elucidate the molecular
mechanism underlying constitutive plasma membrane targeting, the present
work compares the membrane docking reactions of the isolated wild type
and E17K AKT1 PH domains. In vitro studies reveal that the E17K mutation
dramatically increases the affinity for the constitutive plasma membrane lipid
PI(4,5)P2. The resulting PI(4,5)P2 equilibrium affinity is indistinguishable
from that of the standard PI(4,5)P2 sensor, PLCd1 PH domain. Kinetic stud-
ies indicate that the effects of E17K on PIP lipid binding arise largely from
electrostatic modulation of the dissociation rate. Membrane targeting analy-
sis in live cells confirms that the constitutive targeting of E17K AKT1 PH to
plasma membrane, like PLCd1 PH, stems from PI(4,5)P2 binding. Overall,
the evidence indicates that the molecular mechanism underlying E17K onco-
genesis is a broadened target lipid selectivity that allows high affinity bind-
ing to PI(4,5)P2. Moreover, the findings strongly implicate the native Glu17
side chain as a key element of PIP lipid specificity in the wild type AKT1
PH domain. Other PH domains may employ an analogous anionic residue to
control PIP specificity.
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Retinol dehydrogenases (RDHs) are enzymes that catalyze the interconversion
between retinol and retinal. Not much is known concerning these RDHs. In-
deed, the exact physiological role of many isoforms of RDH and their mem-
brane binding remain unknown. In this work, we have overexpressed, purified
and characterized the membrane binding of one isoform, RDH-11. The cDNA
of RDH-11 and of the truncated RDH-11 (N-terminal deletion, N-del RDH-11)
have been cloned in the pET28a plasmid. Those proteins have been overex-
pressed in E. coli, purified by affinity chromatography, and then concentrated
by ultrafiltration. Their activity has been measured in the presence of its sub-
strate, all-trans retinal, and the reaction was initiated by the addition of its co-
factor, NADPH. The reaction products have been analyzed by HPLC. The data
showed a very high activity of RDH-11. Indeed, 1 mg of protein was enough to
convert nearly 100% of all-trans retinal to all-trans retinol. Membrane binding
